The effect of apolipoprotein E ε4 in the relationships of smoking and drinking to cognitive function

Neuroepidemiology

Volumn 18, Issue 3, 1999, Pages 125-133

  Carmelli, Dorit ^a   Swan, Gary E ^a   Reed, Terry ^b   Schellenberg, Gerard D ^c   Christian, Joe C ^b  

^a SRI INTERNATIONAL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

APOE 4; Cognitive function; Drinking; Smoking

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; AGING; ALLELE; ARTICLE; BRAIN FUNCTION; CIGARETTE SMOKING; COGNITION; DRINKING BEHAVIOR; HUMAN; LIFESTYLE; LIPOPROTEIN METABOLISM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NEUROTRANSMITTER RELEASE; QUALITY OF LIFE; WELLBEING;

EID: 0032970205     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026204     Document Type: Article

References (40)

1. Graves AB, van Duijn CM, Chandra V, Fratiglioni L, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA, Shalat SL, Soininen H, Hofman A: Alcohol and tobacco consumption as risk factors for Alzheimer's disease: A collaborative reanalysis of case-control studies. Int J Epidemiol 1991; 20(suppl2):S 48-57.
2. Haapanen A, Koskenvuo M, Kaprio J, Kesaniemi YA, Heikkila K: Carotid atherosclerosis in identical twins discordant for cigarette smoking. Circulation 1989;80:101-116.
3. Shinton R, Beevers G: Meta-analysis of the relation between cigarette smoking and stroke. BMJ 1989;298: 789-794.
4. Levin ED: Nicotinic systems and cognitive function. Psychopharmacology 1992;108:417-431.
5. 3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: An autoradiographic study. Neurology 1988;38:720-723.
6. Camargo CA: Moderate alcohol consumption and stroke: The epidemiologic evidence. Stroke 1989;20: 1611-1626.
7. Lofti J, Meyer JS: Cerebral hemodynamic and metabolic effects of chronic alcoholism. Cerebrovasc Brain Metab Rev 1989;1:2-23.
8. Saunders PA, Copeland JRM, Dewey ME, Davidson IA, McWilliam C, Sharma V, Sullivan C: Heavy drinking as a risk factor for depression and dementia in elderly men. Br J Psychiatry 1991;159:213-216.
9. Brenner DE, Kukull WA, van Belle G, Bowen JD, McCormick WC, Ten L, Larson EB: Relation between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 1993;43: 293-300.
10. Scherr PA, Albert MS, Funkenstein HH, Cook NR, Hennekens CH, Branch LG, White LR, Taylor JO, Evans DA: Correlates of cognitive function in an elderly community population. Am J Epidemiol 1988; 128:1084-1101.
11. Letenneur L, Dartigues J-F, Commenges D, Barberger-Gateau P, Tessier JF, Orgogozo JM: Tobacco consumption and cognitive impairment in elderly people: A population-based study. Ann Epidemiol 1994;4: 449-454.
12. Launer LJ, Feskens EJM, Kalmijn S, Kromhout D: Smoking, drinking, and thinking. The Zutphen Elderly Study. Am J Epidemiol 1996;143: 219-227.
13. Reed T, Carmelli D, Swan GE, Breitner JCS, Welsh KA, Jarvik GP, Deeb S, Auwerx J: Lower cognitive performance in normal older adult twins carrying the apolipoprotein E ε4 allele. Arch Neurol 1994;51: 1189-1192.
14. Henderson AS, Easteal S, Jorm AF, Mackinnon AJ, Korten AE, Christensen H, Croft L, Jacomb PA: Apolipoprotein E allele ε4, dementia, and cognitive decline in a population sample. Lancet 1995;346: 1387-1390.
15. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Grain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
16. Feinleib M, Garrison RJ, Fabsitz RR, Christian JC, Hrubec Z, Borhani NO, Kannel WB, Rosenman RR, Schwartz JT, Wagner JO: The NHLBI twin study of cardiovascular risk factors: Methodology and summary of results. Am J Epidemiol 1977;106:284-295.
17. Jablon S, Neel JV, Gershowitz H, Atkinson GF: The NAS-NRC twin panel: Methods of construction of the panel, zygosity diagnosis and proposed use. Am J Hum Genet 1967;19:133-161.
18. Fabsitz RR, Kalousdian S, Carmelli D. Robinette D, Christian JC: Characteristics of participants and nonparticipants in the NHLBI Twin Study. Acta Genet Med Gemellol (Roma) 1988;37:217-228.
19. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20. Wechsler D: Manual: Wechsler Adult Intelligence Scale-revised. New York, Psychological Corp, 1974.
21. Eslinger PJ, Damasio AR, Benton AL: The Iowa Battery for Mental Decline. Iowa, University of Iowa, 1984.
22. Swan GE, Carmelli D, Reed T, Harshfield GA, Fabsitz RR, Eslinger PJ: Heritability of cognitive performance in aging twins: The National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 1990; 47:259-262.
23. Reed T, Slemenda CW, Viken RJ, Christian JC, Carmelli D, Fabsitz RR: Correlations of alcohol consumption with related covariates and heritability estimates in older adult males over a 14- to 18-year period: the NHLBI Twin Study. Alcohol Clin Exp Res 1994;18:702-710.
24. Reed T, Quiroga J, Selby JV, Carmelli D, Christian JC, Fabsitz RR, Grim CE: Concordance of ischemic heart disease in the NHLBI Twin Study after 14-18 years of follow-up. J Clin Epidemiol 1991;44:797-805.
25. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31: 545-548.
26. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D: Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994;6:29-32.
27. Efron B, Tibshirani R: Bootstrap methods for standard errors, confidence intervals and other measures of statistical accuracy. Stat Sci 1986; 1:54-77.
28. Swan GE, Carmelli D, LaRue A: Relationship between blood pressure during middle age and cognitive impairment in old age: The Western Collaborative Group Study. Aging Neuropsychol Cogn 1996;3:241-250.
29. Yang Q, Khoury MJ: Evolving methods in genetic epidemiology. III. Gene-environment interaction in epidemiologic research. Epidemiol Rev 1997;19:33-43.
30. Carmelli D, Page W: Twenty-four year mortality in World War II US male veteran twins discordant for cigarette smoking. Int J Epidemiol 1996;25:554-558.
31. Carmelli D, Swan GE, Robinette D, Fabsitz R: Genetic influences on smoking - A study of male veteran twins. N Engl J Med 1992;327:829-833.
32. Lee PN: Smoking and Alzheimer's disease: A review of the epidemiologic evidence. Neuroepidemiology 1994;13:131-144.
33. van Duijn CM, Havakes LM, Broeckhoven CV, de Knijff P, Hofman A: Apolipoprotein E genotype and association between smoking and early onset of Alzheimer's disease. BMJ 1995;310:627-631.
34. Plassman BL, Helms MJ, Welsh KA, Saunders AM, Breitner JC: Smoking, Alzheimer's disease, and confounding with genes (letter). Lancet 1995;345:387.
35. Nitta A, Katono Y, Itoh A, Hasegawa T, Nabeshima T: Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system. Pharmacol Biochem Behav 1995;49:807-812.
36. Newhouse PA, Potter A, Corwin J, Lenox R: Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology 1994;10:93-107.
37. Poirier I, Aubert I, Dea D, Quiron R: Apolipoprotein E4 and cholinergic dysfunction in Alzheimer's disease; in Giacobini E (ed): Proceedings of Springfield Meeting on Alzheimer's Disease. Cambridge, Birkhauser, 1994, pp 72-76.
38. Gaziano KM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, Van-Denburgh M, Willett W, Hennekens CH: Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-1834.
39. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
40. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance MA, Schmechel D, Saunders AM, Goldgaber D, Roses AD: Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:8098-8102.